Retatrutide + Cagrilintide 15mg (RETA/CAG)

Product overview

RETA/CAG is a dual-component lyophilized research blend of retatrutide (12.5 mg) and cagrilintide (2.5 mg) in a 15 mg catalog unit — not a dual-strength GLP-3 RT kit. VaultLabs supplies this retatrutide + cagrilintide blend for comparative in vitro laboratory studies with independent lot tracking from single-sequence GLP-3 RT SKUs. Strictly for qualified analytical research — not for human or animal consumption.

Lyophilized peptide blend · HPLC verification on published COA · VaultLabs code VL-RETA-CAG-15 · Appearance: White to off-white lyophilized blend

Technical specifications

Full product name

Retatrutide + Cagrilintide 15mg (RETA/CAG)

Product category

Research Peptides

Product code

25

Strength / amount

15 mg blend

Physical form

Lyophilized

Purity

99.89%%

Testing method

HPLC

Laboratory

Independent Analytical Laboratory (UAE)

Test date

2026-07-15

Current lot number

VL-RETACAG-20260801

Manufacturing / packaging date

2026-07-01

Country of origin

United Arab Emirates (dispatch)

Chemical identifiers

Chemical name

Retatrutide + cagrilintide research blend

Synonyms

RETA/CAG, retatrutide 12.5 mg + cagrilintide 2.5 mg

Product code

VL-RETA-CAG-15

Grade

Research grade — for in vitro laboratory research use only

Material class

Lyophilized peptide blend

Storage and handling

2–8 °C · protect from light

Store sealed lyophilized material at 2–8 °C, protected from light and moisture until opened under laboratory conditions.

Shipping information

Shipping / packaging

Cold-chain aware insulated packaging on UAE dispatch with lot traceability.

Availability

In stock

Dispatch estimate

1–3 UAE business days

VAT

5% VAT (AED) where applicable